MetLife Investment Management’s Ginkgo Bioworks DNA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $273K | Buy |
+24,247
| New | +$273K | ﹤0.01% | 2014 |
|
|
2024
Q2 | – | Sell |
-915
| Closed | -$42.5K | – | 2891 |
|
|
2024
Q1 | $42.5K | Buy |
915
+13
| +1% | +$603 | ﹤0.01% | 2729 |
|
|
2023
Q4 | $61K | Sell |
902
-5
| -0.6% | -$338 | ﹤0.01% | 2758 |
|
|
2023
Q3 | $65.6K | Buy |
907
+2
| +0.2% | +$145 | ﹤0.01% | 2784 |
|
|
2023
Q2 | $67.4K | Buy |
905
+287
| +46% | +$21.4K | ﹤0.01% | 2858 |
|
|
2023
Q1 | $32.9K | Buy |
618
+2
| +0.3% | +$106 | ﹤0.01% | 2748 |
|
|
2022
Q4 | $41.7K | Buy |
616
+22
| +4% | +$1.49K | ﹤0.01% | 2775 |
|
|
2022
Q3 | $74.1K | Sell |
594
-8
| -1% | -$998 | ﹤0.01% | 2731 |
|
|
2022
Q2 | $57.3K | Buy |
+602
| New | +$57.3K | ﹤0.01% | 2800 |
|